hotspot -WSS

hotspot

author：Wikipedia 2025-09-30 22:41:27 - browse：55

Gene therapy helped Conner Curran, right, walk, but as the drug fades, his family is supporting scientific efforts to allow him and other boys get a second dose. -- Biotech coverage from STAT — Gene therapy helped Conner Curran (at right) walk, but as the drug fades, his family is supporting scientific efforts to allow him and other boys get a second dose. Courtesy Jess & Chris Curran

In the beginning, Conner Curran ran up the stairs.

It was a miraculous moment for him and his parents, Jess and Chris Curran. Just months before, contractors were in their New York home to install a motorized lift, while Jess tearfully explained that it wasn’t for a grandparent but for their 7-year-old son, who suffered from Duchenne muscular dystrophy and could barely haul himself up the steps.

Then Conner was accepted as the first patient in Pfizer’s Duchenne gene therapy trial. Three weeks later, he could bound to the second floor. Soon, he could walk the two-plus miles to Goldberg’s, a local bagel shop. “I couldn’t do that before,” he told NPR in 2020.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： ChatGPT in medicine: STAT answers readers' burning questions
Next article： Meta's Zuckerberg and Chan on track to put $50 billion into science

hotspot

WSS

Maker of FluMist seeks to allow at

Prime Medicine, Myeloid Therapeutics clash over genome

Meta's Zuckerberg and Chan on track to put $50 billion into science

Hospitals owned by private equity see complications spike 25%

SNAP should offer more nutrition education

FDA has safety concerns on CRISPR

knowledge

hotspot

leisure time

Sports medicine is finally prioritizing gender equality

Medicare drug price negotiation hasn't dried up venture capital

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Medtronic CEO on promising devices for diabetes, hypertension

Anesthesiologist group: stop taking Ozempic before surgery

Albert Bourla of Pfizer: worst biopharma CEO of 2023

In age of alternative facts, a scholarly course on calling out crap

In Spain, a hospital brews its own CAR

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Christmas in the PICU brings some surprising joy

leisure time

Readout Newsletter: The latest from Bristol, Sarepta, and Novartis

Paying for Covid pills will soon shift to insurers

Medicare Advantage beneficiaries sue Humana over algorithm use

Medicare Advantage beneficiaries sue Humana over algorithm use

CRISPR gene editing developments we’re watching in 2024

HCA sued by state AG for quality issues at Mission Health

focus

hotspot

hotspot

focus